Identifying the risk of disease progression after surgery for localized renal cell carcinoma

BJU International

Volumn 106, Issue 9, 2010, Pages 1277-1283

  Abel, E Jason ^a   Culp, Stephen H ^a   Meissner, Matthew ^a   Matin, Surena F ^a   Tamboli, Pheroze ^a   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

follow up; nephron sparing surgery; renal cell carcinoma; secondary malignancy; surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER SURGERY; DATA BASE; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR DIFFERENTIATION; TUMOR NECROSIS;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEPHRECTOMY; PROGNOSIS;

EID: 78349296829     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09337.x     Document Type: Article

References (30)

1. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK,. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-4
2. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR,. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78-83
3. Rouviere O, Bouvier R, Negrier S, Badet L, Lyonnet D,. Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? Nat Clin Pract Oncol 2006; 3: 200-13
4. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-84
5. Sodickson A, Baeyens PF, Andriole KP, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 2009; 251: 175-84
6. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P,. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166: 63-7
7. Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS,. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005; 174: 466-72
8. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97: 1663-71
9. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW,. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 2008; 179: 2146-51
10. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20: 4559-66
11. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
12. Skolarikos A, Alivizatos G, Laguna P, De La Rosette J,. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 2007; 51: 1490-500
13. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED,. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008; 113: 450-60
14. Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML,. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int 2009; 104: 778-85
15. Horner M, Ries LAG, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute, 2009: [cited Based on November 2008 SEER data submission, posted to SEER website 2009]; Available at:. Accessed 15 November 2009
16. Gofrit ON, Shapiro A, Kovalski N, Landau EH, Shenfeld OZ, Pode D,. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery. Eur Urol 2001; 39: 669-74
17. Levy DA, Slaton JW, Swanson DA, Dinney CP,. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998; 159: 1163-7
18. Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172: 58-62
19. Aron M, Nguyen MM, Stein RJ, Gill IS,. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 2008; 54: 133-40
20. Lane BR, Babineau D, Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 2007; 178: 429-34
21. Luciani LG, Cestari R, Tallarigo C,. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 2000; 56: 58-62
22. Delahunt B,. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology 1999; 31: 185-90
23. Mian BM, Bhadkamkar N, Slaton JW, et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 2002; 167: 65-70
24. Sella A, Logothetis CJ, Ro JY, Swanson DA, Samuels ML,. Sarcomatoid renal cell carcinoma. A treatable entity. Cancer 1987; 60: 1313-8
25. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002; 26: 281-91
26. Sengupta S, Lohse CM, Leibovich BC, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005; 104: 511-20
27. Klatte T, Said JW, De Martino M, et al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol 2009; 181: 1558-64
28. Jewett MA, Zuniga A,. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am 2008; 35: 627-34
29. Ljungberg B, Alamdari FI, Rasmuson T, Roos G,. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999; 84: 405-11
30. Saitoh H,. Distant metastasis of renal adenocarcinoma in patients with a tumor thrombus in the renal vein and/or vena cava. J Urol 1982; 127: 652-3